ZEB1 and prostate cancer: Interestingly, we observed an upregulation of ZEB1, NOG and slightly of FST in a docetaxel resistant subclone of DU145 prostate cancer cells, supporting our data of correlated ZEB1 and BMP-inhibitor expression, here during ZEB1 mediated induction of chemoresistance [34, 35] (Fig. S1C).